Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2010
12/15/2010CN101912519A Medicament for treating coronary disease and preparation method thereof
12/15/2010CN101912493A Acupoint plaster for treating cardiovascular and cerebrovascular diseases
12/15/2010CN101912491A Pills for treating cardiovascular diseases and preparation method
12/15/2010CN101912484A Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia
12/15/2010CN101912482A Traditional Chinese medical powder for treating congenital heart diseases
12/15/2010CN101912473A Medicinal composition for radically treating haemorrhoids
12/15/2010CN101912467A Functional food suitable for crowd suffering from hemorrhoids
12/15/2010CN101912441A Effective part composite containing salvia miltiorrhiza bunge and panax pseudoginseng and preparation method and application thereof
12/15/2010CN101912440A Quality control method of complex salvia tablet and application thereof
12/15/2010CN101912438A Extraction technology of total alkaloids of sophora alopecuroides
12/15/2010CN101912436A Ultrasonic extraction method of alfalfa saponin
12/15/2010CN101912434A Medicament for treating hypertension and insomnia and preparation method thereof
12/15/2010CN101912412A Zeolites for delivery of nitric oxide
12/15/2010CN101912408A Application of alginate sulfuric ester in preparing drugs for preventing and treating diabetes and vascular diseases
12/15/2010CN101912393A Solid preparation of clopidogrel or medicinal salts of clopidogrel and preparation method thereof
12/15/2010CN101912390A Medicinal composite containing irbesartan
12/15/2010CN101912380A Compounds for the treatment of metabolic disorders
12/15/2010CN101912372A Nilvadipine liposome tablets
12/15/2010CN101912364A Ginkgolide B liposome medicinal composition
12/15/2010CN101912180A Multifunctional drug shoe pad capable of simultaneously carrying out pharmacotherapy, magnetotherapy and phototherapy
12/15/2010CN101564536B Sustained and controlled release preparation for pharmaceutical composition for curing hypertension
12/15/2010CN101564505B Chinese medicament for treating pulmonary heart disease
12/15/2010CN101564394B Pharmaceutical composition containing ivabradine and trimetazidine
12/15/2010CN101411770B Medicament for treating blood stasis accumulation type multiple sclerosis symptoms
12/15/2010CN101406671B Chinese medicament preparation for treating cardiac extra systole
12/15/2010CN101401927B Chinese medicine powder for treating apoplexy
12/15/2010CN101323634B Induced nuclear receptor TR3 expressed cardiac glycoside compounds and use thereof
12/15/2010CN101314002B Medicament for treating blood supply insufficiency of brain
12/15/2010CN101313970B Medicament for treating hemorrhoids and use method
12/15/2010CN101306167B Antihypertensive traditional Chinese medicine and preparation method thereof
12/15/2010CN101297864B Preparation of Xia sang ju formulation
12/15/2010CN101292984B Hydroxide benzenesulfonic acid alkyl pyrazine medicaments, preparation method and application thereof
12/15/2010CN101288650B Edaravone lyophilized preparation and preparation technique thereof
12/15/2010CN101264077B Lignans and its use for preparing antiphlogistic antiendotoxin medicaments
12/15/2010CN101254181B Hypertension-treating medicine combination
12/15/2010CN101233885B Health tea
12/15/2010CN101181483B Chinese patent drug for curing cataptosis and hemiparalysis sequela
12/15/2010CN101164546B Vein-relaxing pain-relieving medicinal composition and preparation method and use thereof
12/15/2010CN101161253B Pharmaceutical composition of melon betel or its extract and safflower or its extract
12/15/2010CN101143164B Medicinal composition for treating coronary heart disease and preparation process thereof
12/15/2010CN101138635B Fibrin glue vasodilation agent sustained-release long-acting composition
12/15/2010CN101096346B New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them
12/15/2010CN101006999B Therapeutic uses and compositions of isoflavones
12/14/2010US7851635 which comprises thiadiazoline derivatives, effective in treatment of a disease associated with cell proliferation, such as restenosis, cardiac hypertrophy and immunologic diseases
12/14/2010US7851589 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage
12/14/2010US7851588 Corticotropin releasing factor peptide for use in the treatment of nervous system and hypertensive disorders; (cyclo 31-34)[Ac-Pro4,D-Phe12,Nle18,21,Glu31,Lys34]-sucker urotensin
12/14/2010US7851586 Peptides for activation and inhibition of δPKC
12/14/2010US7851507 Administering to a lung cancer patient 2-hydroxyoleic acid in an amount effective to inhabit proliferation of the cancer; leukemia, brain metastasis
12/14/2010US7851503 xanthocillin analogues such as 3,3'-Dimethoxyxanthocillin X dimethyl ether, used for increasing platelets in a human having a disease selected from thrombocytopenia caused by bone marrow grafting, surgery, infection, intestinal bleeding, anemia, myelodysplastic syndrome, and thrombopoietin deficiency
12/14/2010US7851494 administering 5-[(4-(2,6-difluorobenzyloxy)phenyl)-methyl]-1H-tetrazole for the treatment of insulin resistance, diabetes, hyperlipemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
12/14/2010US7851492 Administering 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea activates an ERG channel; arrhythmia; cardiac ishemia, ishcemic heart disease, hypertrophic heart, cardiomyopathia or failing heart
12/14/2010US7851472 Cyclopropanecarboxylic acid {4-[3-(4-methoxy-phenyl)-[1,2,4]triazolo[3,4-a]phthalazin-6-ylamino]-phenyl}-amide; phosphodiesterase inhibitors; neoangiogenesis or inflammatory disease
12/14/2010US7851444 χ-conotoxin peptides (-1)
12/14/2010US7851442 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin)
12/14/2010US7851181 Generating monoclonal antibodies specific to insulin-like growth factor receptor-I (IGFR1) for use in treatment and prevention of cell proliferative disorders
12/14/2010US7851167 Using stem cells expressing stage specific embryonic antigen (SSEA) as tools in identifying modulators for treatment of cardiovascular disorders
12/14/2010US7850993 Drug-releasing system of biodegradable polymer type
12/14/2010US7850963 Vascular endothelial growth factor 2
12/14/2010CA2485641C Novel condensed imidazole derivatives
12/14/2010CA2470480C Indolinone derivatives useful as protein kinase inhibitors
12/14/2010CA2470044C Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/14/2010CA2417484C Elongase genes and uses thereof
12/14/2010CA2414941C Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
12/14/2010CA2412723C Benzothiazolyl ppar-gamma modulators
12/14/2010CA2373433C Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
12/14/2010CA2366857C Phthalazine derivatives for treating inflammatory diseases
12/14/2010CA2336781C Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics
12/14/2010CA2285937C Modified proteins which bind extracellular matrix components
12/14/2010CA2159546C Cycloalkano-indole and -azaindole derivatives
12/09/2010WO2010141879A2 Peptides for transport of therapeutics and their carriers in mouse models and humans
12/09/2010WO2010141771A1 Nucleic acid modulators of glycoprotein vi
12/09/2010WO2010141600A2 Improved method for synthesizing pirfenidone
12/09/2010WO2010141525A1 Active metabolite of a thrombin receptor antagonist
12/09/2010WO2010141494A2 Synthesis of ezetimibe
12/09/2010WO2010141424A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/09/2010WO2010140855A2 Pharmaceutical composition or functional food composition for the treatment, prevention or alleviation of cardiac hypertrophy comprising raspberry extract
12/09/2010WO2010140685A1 Heterocyclic compound and hematopoietic stem cell amplifier
12/09/2010WO2010139985A1 The use of amlexanox in the therapy of neutrophil-driven diseases
12/09/2010WO2010139967A1 Dihydroindole and tetrahydroisoquinoline derivatives useful as potassium channel inhibitors
12/09/2010WO2010139180A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof
12/09/2010WO2010139063A1 Diagnosis of restenosis in patients undergoing percutaneous coronary intervention
12/09/2010WO2010139026A1 Therapeutic and diagnostic molecules
12/09/2010WO2010102402A3 Compositions and methods for management of peripheral arterial disease
12/09/2010WO2010093460A3 Particle size-structured parenteral dispersions
12/09/2010WO2010000801A3 Whey protein hydrolysate containing tryptophan peptide consisting of alpha lactalbumin and the use thereof
12/09/2010WO2009127944A8 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
12/09/2010US20100313286 G protein-related kinase mutants in essential hypertension
12/09/2010US20100313285 Altering High Density Lipoprotein Levels Through UDP-N-Acetyl-Alpha-D-Galactosamine: Polypeptide N-Acetlgalactosaminyltransferase (GALNT) Modulation
12/09/2010US20100312328 Drug-delivery endovascular stent and method of forming the same
12/09/2010US20100312312 Method for selective photodynamic therapy and light source for implementation thereof
12/09/2010US20100311840 Oral formulations of bis(thiohydrazide amides)
12/09/2010US20100311829 Novel Therapeutic Uses of Beta-3 Adrenergic Receptor Agonist Derivatives in Particular to Modulate Apoptosis
12/09/2010US20100311822 ACE2 Activation For Treatment Of Heart, Lung and Kidney Disease and Hypertension
12/09/2010US20100311820 Nucleic acid modulators of glycoprotein vi
12/09/2010US20100311810 Modulation of diacylglycerol acyltransferase 2 expression
12/09/2010US20100311800 Angiotensin ii receptor antagonists
12/09/2010US20100311799 Polycyclic antagonists of lysophosphatidic acid receptors
12/09/2010US20100311795 1,3-dioxane carboxylic acids
12/09/2010US20100311792 Benzenesulfonamide Compounds and the Use Thereof
1 ... 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 ... 1595